Precision Therapeutics

Precision therapeutics is enabled by targeted manipulation of synthetic material interactions with biological systems. Talented chemists and biologists at Zymeron develop a portfolio of biointerfacing technologies to precisely control the trafficking of chemical compounds and nanoparticles in living systems and their engagement with molecular and cellular targets including membrane proteins, subcellular organelles and tissue markers.